About Technology Issues FAQ

Links

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.